Skip to main content
. 2018 Apr 9;7(5):R196–R211. doi: 10.1530/EC-18-0079

Figure 2.

Figure 2

Management of dysthyroidism induced by PD-1/PD-L1 antibodies. ATD, anti-thyroid drugs; BB, beta-blocker; CS, corticosteroid; fT4, free thyroxine; TRAb, TSH receptor antibodies; TRH, thyroid hormone replacement; TSH, thyroid-stimulating hormone; US, ultrasound. *If persistence of hyperthyroidism with suspicion of autoimmune underlying cause.